News

The hidden cyber risk you’re probably ignoring: User access reviews
This guide provides an eight-step process for establishing and conducting a quality access review that will satisfy multiple ...
Le Lézard9h
Taiho Oncology and Cullinan Therapeutics Announce Pivotal REZILIENT1 Phase 1/2 Data Published in the Journal of Clinical Oncology
Taiho Oncology, Inc., and Cullinan Therapeutics, Inc., announced today the publication of positive results from the REZILIENT1 trial in the peer-reviewed Journal of Clinical Oncology (JCO). REZILIENT1 ...